THERAVANCE INC's ticker is THRX and the CUSIP is 88338T104. A total of 121 filers reported holding THERAVANCE INC in Q3 2015. The put-call ratio across all filers is 2.05 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $7,226,000 | -19.1% | 399,913 | +38.5% | 0.04% | -56.9% |
| Q1 2014 | $8,934,000 | -73.3% | 288,744 | -69.3% | 0.10% | -76.7% |
| Q4 2013 | $33,506,000 | +125.9% | 939,872 | +159.0% | 0.44% | +118.5% |
| Q3 2013 | $14,830,000 | +406.7% | 362,850 | +377.6% | 0.20% | +308.2% |
| Q2 2013 | $2,927,000 | – | 75,973 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baupost Group | 19,815,983 | $338,655,000 | 5.90% |
| Litespeed Management, L.L.C. | 2,670,695 | $45,642,000 | 1.76% |
| CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD | 2,790,913 | $47,697,000 | 1.76% |
| Proxima Capital Management, LLC | 915,000 | $15,637,000 | 1.69% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 8,196,372 | $140,076,000 | 1.44% |
| PERRY CAPITAL | 1,831,099 | $31,293,000 | 1.14% |
| Roundview Capital LLC | 140,145 | $2,395,000 | 1.08% |
| SECTORAL ASSET MANAGEMENT INC | 971,438 | $16,602,000 | 0.70% |
| Realm Partners LLC | 139,982 | $2,392,000 | 0.68% |
| BB BIOTECH AG | 743,244 | $12,702,000 | 0.52% |